We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSF icon
5026
Laird Superfood
LSF
$48.2M
$6K ﹤0.01%
2,893
+2,612
+930% +$5.78K
MCI
5027
Barings Corporate Investors
MCI
$344M
$6K ﹤0.01%
+433
New +$6.01K
LITS
5028
Lite Strategy Inc
LITS
$30.5M
$6K ﹤0.01%
833
-295
-26% -$3.04K
MHH icon
5029
Mastech Digital
MHH
$95.3M
$6K ﹤0.01%
418
– –
MIND icon
5030
MIND Technology
MIND
$42.6M
$6K ﹤0.01%
942
-26
-3% -$200
NGNE icon
5031
Neurogene
NGNE
$713M
$6K ﹤0.01%
499
+18
+4% +$367
NMFC icon
5032
New Mountain Finance
NMFC
$736M
$6K ﹤0.01%
494
-2,933
-86% -$37.4K
NUWE icon
5033
Nuwellis
NUWE
$474K
– –
0
– –
OCC icon
5034
Optical Cable Corp
OCC
$147M
$6K ﹤0.01%
1,739
+874
+101% +$3.19K
OPHC icon
5035
OptimumBank Holdings
OPHC
$116M
$6K ﹤0.01%
1,625
+1,529
+1,593% +$6.12K
PGX icon
5036
Invesco Preferred ETF
PGX
$3.77B
$6K ﹤0.01%
537
-894
-62% -$11.3K
PW
5037
Power REIT
PW
$2.93M
$6K ﹤0.01%
64
-6
-9% -$888
HTT
5038
High Templar Tech Ltd
HTT
$391M
$6K ﹤0.01%
6,886
-2,286
-25% -$2.45K
RDHL
5039
Redhill Biopharma
RDHL
$3.62M
$6K ﹤0.01%
12
+8
+200% +$6.97K
RKDA icon
5040
Arcadia Biosciences
RKDA
$1.24M
$6K ﹤0.01%
282
-20
-7% -$682
RNAZ icon
5041
TransCode Therapeutics
RNAZ
$3.68M
– –
0
– –
RZLT icon
5042
Rezolute
RZLT
$443M
$6K ﹤0.01%
+2,276
New +$6.57K
SAN icon
5043
Banco Santander
SAN
$211B
$6K ﹤0.01%
2,796
-5,437
-66% -$13.6K
SAR icon
5044
Saratoga Investment
SAR
$314M
$6K ﹤0.01%
+301
New +$7.24K
SBFG icon
5045
SB Financial Group
SBFG
$171M
$6K ﹤0.01%
327
+227
+227% +$3.92K
SCHV
5046
Schwab US Large-Cap Value ETF
SCHV
$16.3B
$6K ﹤0.01%
309
-8,994
-97% -$194K
BNKK
5047
Bonk Inc
BNKK
$8.16M
$6K ﹤0.01%
221
-137
-38% -$3.53K
SLYG icon
5048
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
$6K ﹤0.01%
82
– –
SNES icon
5049
SenesTech
SNES
$6.78M
$6K ﹤0.01%
7
+2
+40% +$2.48K
SONN
5050
DELISTED
Sonnet BioTherapeutics
SONN
$6K ﹤0.01%
24
+20
+500% +$11.7K
200 201
202
203 204

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.